A recent survey amongst selected pharma companies, conducted by Rondo, confirmed the current trend to smaller lot sizes in drug production. Product launches, various country artworks, penetration into the “pharmerging markets” as well as surging investment into the development of “orphan drugs” (drugs that treat very rare diseases), all lead to smaller lot sizes in pharma production. Rondo has embraced this trend at an early stage. The recent introduction of a digital printing production line at Rondo combines well with the existing state of the art offset technology to respond flexibly to all sorts of customer demands - from 10 folding boxes to ...you name it.
T +41 61 486 87 87
F +41 61 486 87 50